Europe Endoscopy Devices Market Outlook To 2019 - Capsule Endoscope Systems, Endoscopic Instruments,

Capsule endoscopy could identify presence of "occult" blood at very low levels

The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Scope Countries covered include France, Germany, Italy, Spain and United Kingdom. - Market size and company share data for Endoscopy Devices market categories - Capsule Endoscope Systems, Endoscopic Instruments, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Endoscopy Visualization Systems, Flexible Endoscopes and Rigid Endoscopes.- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2005 to 2012, forecast forward for 7 years to 2019. - 2012 company shares and distribution shares data for each of the market categories and countries.- Global corporate-level profiles of key companies operating within the Europe Endoscopy Devices market..- Key players covered include Olympus Corporation, Hoya Corporation, Fujifilm Holdings Corporation, KARL STORZ GmbH & Co. KG, Given Imaging Ltd., Richard Wolf GmbH and others. Reasons to buy Develop business strategies by identifying the key market categories and segments poised for strong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Europe Endoscopy Devices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Table of Contents 1 Table of Contents 21.1 List of Tables 81.2 List of Figures 112 Introduction 132.1 What is This Report About? 1179.8.1 Company Overview 1179.9 Medivators Inc. 1179.9.1 Company Overview 1179.10 Soluscope SAS 1189.10.1 Company Overview 1189.11 B. Braun Melsungen AG 1189.11.1 Company Overview 1189.12 Steris Corporation 1189.12.1 Company Overview 1189.13 Getinge AB 1199.13.1 Company Overview 1199.14 IntroMedic Co., Ltd. 1199.14.1 Company Overview 1199.15 Custom Ultrasonics Incorporated 1209.15.1 Company Overview 1209.16 Wassenburg Medical Devices B.V. KG Given Imaging Ltd. Richard Wolf GmbH Stryker Corporation Advanced Sterilization Products Services Inc.Medivators Inc. visite site

Details of the invention and initial trials are described in a forthcoming issue of the International Journal of Biomedical Engineering and Technology. Hongying Liu, Panpan Qiao, Xueli Wu, Lan Zhu, Xitian Pi and Xiaolin Zheng of Chongqing University, in China, have adapted capsule endoscopy to allow them to detect tiny quantities of blood that might be present in a patient with the earliest signs of stomach cancer. The capsule is encased in non-toxic and acid-safe polycarbonate. It carries inside it a detector, power supply, and wireless transmitter. The device has a detection limit of 6 micrograms per liter of fluid and laboratory tests demonstrate its simplicity as well as its reliability. Once its task is complete the tiny pill-like device would be disposed of through the usual route without harm to the stomach or intestine. This approach thus avoids the uncomfortable and risk retrieval of such a device via the oral route. Occult bleeding is usually first identified in patients who have given a stool sample in which blood is found. However, it is important to identify the source of such blood, whether intestine or stomach. The detection of occult blood is indicated as one method of early diagnosis and so reduction of mortality from gastrointestinal cancers given the availability and adoption of suitable treatment by the patient. The next step is to take the patent-pending device to clinical safety testing and then to in patients. It is so far likely to prove safe to use, less invasive than other endoscopic technology and devices. source news